{{Rsnum
|rsid=2283792
|Gene=MAPK1
|Chromosome=22
|position=21776836
|Orientation=plus
|GMAF=0.4591
|Gene_s=MAPK1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 31.9 | 41.6 | 26.5
| HCB | 19.1 | 55.1 | 25.7
| JPT | 13.4 | 52.7 | 33.9
| YRI | 47.6 | 44.2 | 8.2
| ASW | 35.1 | 43.9 | 21.1
| CHB | 19.1 | 55.1 | 25.7
| CHD | 22.0 | 56.0 | 22.0
| GIH | 25.7 | 50.5 | 23.8
| LWK | 40.9 | 50.9 | 8.2
| MEX | 36.2 | 41.4 | 22.4
| MKK | 44.2 | 40.4 | 15.4
| TSI | 29.4 | 53.9 | 16.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21833088
|Trait=None
|Title=Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
|RiskAllele=C
|Pval=5E-9
|OR=1.1000
|ORtxt=[1.08-1.11]
|OA=1
}}

{{PMID|17357082|OA=1
}} Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}